by DMCBiotech | Mar 15, 2022 | DMC Press Releases
15 March 2022 – Kelly Smith, Ph.D. has joined DMC Biotechnologies as VP R&D. Previously, she was Head of Bioprocessing and Formulation Development at Joyn Bio. Kelly has more than 20 years of experience building and leading research and development teams and has a...
by DMCBiotech | Mar 18, 2021 | DMC Press Releases, News
15 March 2021 – DMC Biotechnologies has successfully demonstrated full commercial scale (85m3 fermentation at EW Biotech, Germany) for its first product, the amino acid L-alanine. The scale-up results identically tracked the performance at bench and pilot scales,...
by DMCBiotech | Feb 6, 2020 | DMC Press Releases, News
06 February 2020 – DMC Biotechnologies has successfully produced its lead product, L-alanine at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3 scale fermentation and for each of the...
by DMCBiotech | Jun 9, 2019 | DMC Press Releases, News
June 9th 2019 – DMC (www.dmcbio.com), an early-stage biotechnology company, announced today that is has raised a Series A equity financing led by Sofinnova Partners. The company also announced the addition to its Board of Directors of Josko Bobanovic, Partner and...
by DMCBiotech | May 18, 2019 | DMC Press Releases, News
A Bass Connections project, Duke Undergraduate International Genetically Engineered Machine (iGEM) Team, has received two external grants to support its work. The Duke iGEM team is led by faculty members Nicolas Buchler, Charles Gersbach and Michael Lynch. Student...
